BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 3359945)

  • 1. Synovial fluid and plasma kinetics of repeat dose sustained action tiaprofenic acid in patients with rheumatoid arthritis.
    Nichol FE; Samanta A; Rose CM
    Drugs; 1988; 35 Suppl 1():46-51. PubMed ID: 3359945
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reduction of prostaglandin E2 concentrations in synovial fluid of patients suffering from rheumatoid arthritis following tiaprofenic acid or indomethacin treatment.
    Daymond TJ; Rowell FJ
    Drugs; 1988; 35 Suppl 1():4-8. PubMed ID: 3162870
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Trans-synovial kinetics of tiaprofenic acid].
    Kurowski M
    Z Rheumatol; 1988; 47(3):173-6. PubMed ID: 3213265
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics of lumiracoxib in plasma and synovial fluid.
    Scott G; Rordorf C; Reynolds C; Kalbag J; Looby M; Milosavljev S; Weaver M; Huff JP; Ruff DA
    Clin Pharmacokinet; 2004; 43(7):467-78. PubMed ID: 15139795
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical pharmacokinetics of tiaprofenic acid and its enantiomers.
    Davies NM
    Clin Pharmacokinet; 1996 Nov; 31(5):331-47. PubMed ID: 9118583
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics of tiaprofenic acid in normal rabbits and rabbits subjected to joint immobilisation.
    Meyer-Carrive I; Graham GG; Ghosh P
    Agents Actions; 1993 May; 39(1-2):59-68. PubMed ID: 8285141
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The pharmacokinetics of sustained release tiaprofenic acid in elderly arthritic patients.
    Hosie GA; Hosie J
    Br J Clin Pharmacol; 1987 Jul; 24(1):93-5. PubMed ID: 3620289
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tolmetin kinetics and synovial fluid prostaglandin E levels in rheumatoid arthritis.
    Dromgoole SH; Furst DE; Desiraju RK; Nayak RK; Kirschenbaum MA; Paulus HE
    Clin Pharmacol Ther; 1982 Sep; 32(3):371-7. PubMed ID: 7105628
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A comparison of a sustained release preparation of tiaprofenic acid with the conventional tablet formulation and a placebo in rheumatoid arthritis.
    Essigman W; Lambert J; Sheldon P; Sweetman BJ; Wojtulewski J
    Int J Clin Pharmacol Res; 1987; 7(4):251-7. PubMed ID: 3596867
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The transsynovial distribution of oxaprozin.
    Kurowski M; Thabe H
    Agents Actions; 1989 Jun; 27(3-4):458-60. PubMed ID: 2801338
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics of sustained action tiaprofenic acid in elderly arthritic patients.
    Hosie GA; Hosie J
    Drugs; 1988; 35 Suppl 1():52. PubMed ID: 3359946
    [No Abstract]   [Full Text] [Related]  

  • 12. Disappearance kinetics of solutes from synovial fluid after intra-articular injection.
    Owen SG; Francis HW; Roberts MS
    Br J Clin Pharmacol; 1994 Oct; 38(4):349-55. PubMed ID: 7833225
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma and synovial fluid concentrations of diclofenac sodium and its hydroxylated metabolites during once-daily administration of a 100 mg slow-release formulation.
    Fowler PD; Dawes PT; John VA; Shotton PA
    Eur J Clin Pharmacol; 1986; 31(4):469-72. PubMed ID: 3469101
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [6-methoxy-2-naphthylacetic acid level in plasma, synovial fluid and adjacent tissue in patients with rheumatoid arthritis or gonarthroses after a 4-day therapy with nabumetone (Arthaxan)].
    Miehlke RK; Schneider S; Sörgel F; Muth P; Henschke F; Fedder M
    Z Rheumatol; 1991; 50(2):103-8. PubMed ID: 1872041
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics of nonsteroidal anti-inflammatory drugs in synovial fluid.
    Day RO; McLachlan AJ; Graham GG; Williams KM
    Clin Pharmacokinet; 1999 Mar; 36(3):191-210. PubMed ID: 10223168
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The pharmacokinetics of etodolac in serum and synovial fluid of patients with arthritis.
    Kraml M; Hicks DR; McKean M; Panagides J; Furst D
    Clin Pharmacol Ther; 1988 May; 43(5):571-6. PubMed ID: 2966693
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A pharmacokinetic comparison of tenoxicam in plasma and synovial fluid.
    Bird HA; Allen JG; Dixon JS; Wright V
    Eur J Rheumatol Inflamm; 1985; 8(1):47-52. PubMed ID: 3879830
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recent findings on the pharmacokinetics of non-steroidal anti-inflammatory drugs in synovial fluid.
    Netter P; Bannwarth B; Royer-Morrot MJ
    Clin Pharmacokinet; 1989 Sep; 17(3):145-62. PubMed ID: 2680211
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Indomethacin kinetics in synovia and plasma following administration of indomethacin Gits 7/85 in patients with chronic polyarthritis].
    Zöller B; Zimmer M; Dittrich P; Lehmann K; Engel HJ; Faust-Tinnefeldt G; Kukovetz WR
    Z Rheumatol; 1983; 42(2):78-81. PubMed ID: 6880406
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The pharmacokinetics of total and unbound concentrations of tenoxicam in synovial fluid and plasma.
    Day RO; Williams KM; Graham S; Handel M
    Arthritis Rheum; 1991 Jun; 34(6):751-60. PubMed ID: 2053921
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.